King’s Best Price Settlement Covers Entire Product Portfolio
Executive Summary
King's settlement of charges that it failed to properly calculate Medicaid best price rebates is far larger than most such settlements because it includes the company's entire portfolio
You may also be interested in...
King Gets Inventories Under Control; Next Step Is Boosting Brand Sales
King Pharmaceuticals has dramatically reduced wholesale inventory levels and associated product return rates this year, the company said during its Nov. 9 third quarter earnings call
King Gets Inventories Under Control; Next Step Is Boosting Brand Sales
King Pharmaceuticals has dramatically reduced wholesale inventory levels and associated product return rates this year, the company said during its Nov. 9 third quarter earnings call
GSK’s AWP Pricing Settlement Includes Expanded Training Of Sales Reps
GlaxoSmithKline's $150 mil. settlement with the Department of Justice requires the company to expand its compliance training for its sales reps